We'd like your feedback
Bimonthly Survey
Image
(Recorded on 1/12/2026)
Long-acting antiretrovirals are now becoming mainstream for the management of people with HIV who are virologically suppressed or for those with drug resistance and limited treatment options. Furthermore, long-acting ART has shown promise to improve treatment outcomes for individuals struggling with adherence to daily oral ART. Data on the currently approved long-acting ART for HIV treatment along with real-world evidence and implementation challenges is the focus of this lecture.
Speaker
Onyema Ogbuagu, MBBCh, FACP, FIDSA
Associate Professor of Medicine (AIDS) and of Pharmacology